The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 524 KB) and Technical Notes (PDF, 762 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 19.31

All Lymphoid Neoplasms With Detailed Non-Hodgkin Lymphoma Subtypesa

SEERb 5-Year Relative Survival (Percent) by Age at Diagnosis
All Races, Females, 2005-2011
Site All Ages Ages 0-19 Ages 20-64 Ages 65+
Count Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval		 Percent 95%
Confidence
Interval
Low High Low High Low High Low High
Lymphoid Neoplasm 76,981 69.5 69.0 69.9 90.2 89.1 91.2 79.2 78.7 79.7 58.7 57.9 59.4
1 Hodgkin Lymphoma 6,796 86.9 85.9 87.8 96.9 95.4 97.9 91.5 90.5 92.4 54.3 50.1 58.3
2 Non-Hodgkin lymphoma 68,074 68.3 67.8 68.8 88.1 86.7 89.3 77.3 76.7 77.9 59.5 58.7 60.2
2(a) Non-Hodgkin lymphoma, B-cell 62,931 68.6 68.1 69.1 88.9 87.4 90.2 78.1 77.4 78.7 60.0 59.2 60.8
2(a) 1. Precursor Non-Hodgkin lymphoma, B-cell 3,391 68.8 67.0 70.6 89.0 87.3 90.4 38.4 34.7 42.0 14.5 9.9 19.9
2(a) 2. Mature Non-Hodgkin lymphoma, B-cell 56,436 68.5 67.9 69.0 87.5 83.2 90.7 79.6 78.9 80.2 60.1 59.3 60.9
2(a) 2.1. Chronic/Small/Prolymphocytic/ Mantle B-cell Non-Hodgkin lymphoma 11,934 79.3 78.0 80.5 - - - 89.1 87.7 90.4 74.0 72.3 75.7
2(a) 2.1.1. Chronic/Small lymphocytic leukemia/lymphoma 10,852 81.6 80.3 82.8 - - - 91.3 89.9 92.5 76.5 74.7 78.2
2(a) 2.1.2. Prolymphocytic leukemia, B-cell 37 27.2 11.8 45.2 - - - - - - - - -
2(a) 2.1.3. Mantle-cell lymphoma 1,045 56.7 52.3 60.8 - - - 69.5 63.4 74.9 48.5 42.6 54.2
2(a) 2.2. Lymphoplasmacytic lymphoma/ Waldenstrom macroglubulinemia 1,175 80.0 75.8 83.5 - - - 87.6 82.5 91.2 75.7 69.6 80.6
2(a) 2.2.1. Lymphoplasmacytic lymphoma 563 73.6 67.1 78.9 - - - 81.7 72.6 88.0 69.2 60.4 76.5
2(a) 2.2.2. Waldenstrom macroglubulinemia 612 85.8 80.0 90.0 - - - 91.5 85.6 95.1 81.7 72.8 87.9
2(a) 2.3. Diffuse large B-cell lymphoma (DLBCL) 15,064 61.3 60.3 62.3 85.4 79.3 89.8 74.7 73.4 75.9 51.0 49.5 52.5
2(a) 2.3.1. DLBCL, NOSc 14,862 61.0 60.0 62.0 87.2 81.0 91.5 74.4 73.1 75.6 51.0 49.5 52.5
2(a) 2.3.2. Intravascular large B-cell lymphoma - - - - - - - - - - - - -
2(a) 2.3.3. Primary effusion lymphoma - - - - - - - - - - - - -
2(a) 2.3.4. Mediastinal large B-cell lymphoma 177 85.6 78.9 90.4 - - - 88.8 82.0 93.1 - - -
2(a) 2.4. Burkitt lymphoma/leukemia 594 54.8 50.2 59.1 88.0 79.3 93.2 55.6 49.4 61.3 34.5 26.9 42.2
2(a) 2.5. Marginal-zone lymphoma (MZL) 4,881 89.8 88.1 91.2 - - - 94.0 92.3 95.3 86.2 83.3 88.6
2(a) 2.5.1. Splenic MZL 417 78.9 72.0 84.2 - - - 86.8 78.5 92.1 72.3 61.4 80.6
2(a) 2.5.2. Extranodal MZL, MALTc type 2,983 94.3 92.1 95.9 - - - 96.5 94.5 97.8 92.1 88.0 94.8
2(a) 2.5.3. Nodal MZL 1,481 83.7 80.4 86.5 - - - 90.1 86.2 92.9 79.0 74.0 83.2
2(a) 2.6. Follicular lymphoma 9,055 87.4 86.2 88.4 - - - 92.7 91.6 93.6 81.1 78.9 83.1
2(a) 2.7. Hairy-cell leukemia 283 89.9 82.2 94.4 - - - 97.7 93.3 99.2 74.2 56.0 85.7
2(a) 2.8. Plasma cell neoplasms 13,443 45.0 43.9 46.2 - - - 59.8 58.1 61.5 35.0 33.4 36.5
2(a) 2.8.1. Plasmacytoma 706 61.0 55.6 65.9 - - - 77.0 70.1 82.5 44.1 36.4 51.6
2(a) 2.8.2. Multiple myeloma/ plasma-cell leukemia 12,737 44.2 43.0 45.3 - - - 58.7 56.9 60.4 34.5 33.0 36.1
2(a) 2.9. Heavy chain disease - - - - - - - - - - - - -
2(a) 3. Non-Hodgkin lymphoma, B-cell, NOSc 3,104 70.7 68.2 72.9 - - - 79.4 76.3 82.1 65.9 62.5 69.1
2(b) Non-Hodgkin lymphoma, T-cell 4,196 65.3 63.5 67.0 84.0 79.2 87.8 71.2 69.1 73.3 51.6 48.2 55.0
2(b) 1. Precursor Non-Hodgkin lymphoma, T-cell 241 63.3 56.2 69.5 88.0 79.5 93.2 48.6 37.9 58.5 19.4 5.9 38.8
2(b) 2. Mature Non-Hodgkin lymphoma, T-cell 3,923 65.7 63.9 67.5 82.4 76.1 87.1 72.8 70.5 74.9 52.4 48.8 55.8
2(b) 2.1. Mycosis fungoides/Sezary syndrome 1,054 90.4 87.2 92.9 89.8 59.0 97.8 92.7 89.4 95.1 85.9 79.7 90.4
2(b) 2.1.1. Mycosis fungoides 1,028 91.9 88.7 94.3 89.8 59.0 97.8 93.3 90.0 95.6 88.2 81.7 92.4
2(b) 2.1.2. Sezary syndrome 26 28.4 9.1 51.6 - - - - - - - - -
2(b) 2.2. Peripheral T-cell lymphoma 2,283 58.8 56.4 61.2 82.9 72.9 89.4 68.8 65.7 71.6 43.5 39.2 47.6
2(b) 2.2.1. Peripheral T-cell lymphoma, NOSc 745 38.8 34.6 43.0 - - - 48.5 42.5 54.3 28.8 23.0 34.9
2(b) 2.2.2. Angioimmunoblastic T-cell lymphoma 343 48.7 42.2 54.8 - - - 59.9 50.7 68.0 39.8 31.0 48.4
2(b) 2.2.3. Subcutaneous panniculitis- like T-cell lymphoma 53 70.6 52.3 83.0 - - - 66.4 41.6 82.6 - - -
2(b) 2.2.4. Anaplastic large cell lymphoma, T-cell or null-cell type 432 62.1 56.6 67.1 82.2 68.3 90.4 72.1 65.8 77.5 30.8 20.8 41.3
2(b) 2.2.5. Hepatosplenic T-cell lymphoma - - - - - - - - - - - - -
2(b) 2.2.6. Enteropathy-type T-cell lymphoma 30 19.7 7.4 36.2 - - - - - - - - -
2(b) 2.2.7. Cutaneous T-cell lymphoma, NOSc 445 83.0 77.1 87.5 - - - 88.5 82.3 92.6 74.0 61.9 82.8
2(b) 2.2.8. Primary cutaneous anaplastic large cell lymphoma 220 90.0 81.6 94.6 - - - 93.0 84.8 96.8 80.6 56.6 92.1
2(b) 2.3. Adult T-cell leukemia/lymphoma 295 48.8 41.7 55.4 80.9 70.8 87.9 32.5 22.5 43.0 25.6 13.1 40.0
2(b) 2.4. NKc/T-cell lymphoma, nasal-type/ agressive NKc-cell leukemia 146 46.7 36.7 56.0 - - - 47.3 35.7 57.9 46.3 27.2 63.4
2(b) 2.5. T-cell large granular lymphocytic leukemia 69 75.3 58.1 86.3 - - - 77.7 51.3 90.9 68.6 43.4 84.3
2(b) 2.6. Prolymphocytic leukemia, T-cell 76 12.7 4.6 25.1 - - - 11.2 1.1 34.7 12.8 3.4 28.4
2(b) 3. Non-Hodgkin lymphoma, NOSc , T-cell 32 33.2 16.9 50.4 - - - - - - - - -
2(c) Non-Hodgkin lymphoma, unknown lineage 947 59.9 56.0 63.5 85.8 80.2 89.9 60.6 53.7 66.8 45.2 39.1 51.1
2(c) 1. Precursor lymphoblastic leukemia/ lymphoma, unknown lineage 411 64.5 59.3 69.2 86.7 81.3 90.6 42.0 31.0 52.6 20.9 11.9 31.6
2(c) 2. Prolymphocytic leukemia, unknown lineage 25 53.4 27.2 73.9 - - - - - - - - -
2(c) 3. Non-Hodgkin lymphoma, NOSc, unknown lineage 511 56.5 50.9 61.7 - - - 71.4 62.8 78.4 50.2 43.1 56.9
2(*) 1. Total precursor lymphoma/leukemiad 4,043 68.1 66.5 69.7 88.7 87.2 90.1 39.8 36.5 43.0 16.3 12.2 21.1
3 Composite Hodgkin lymphoma and Non-Hodgkin lymphoma 40 45.0 23.8 64.2 - - - - - - - - -
4 Lymphoid neoplasm, NOSc 2,071 49.1 46.3 51.8 89.6 71.0 96.5 66.3 61.8 70.3 39.9 36.3 43.4

Footnotes:

a Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695-708.

b SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and Georgia excluding ATL/RG).

c NOS = Not otherwise specified. MALT = Mucosa-associated lymphoid tissue. NK = Natural killer.

- Statistic not displayed due to less than 25 cases.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.